GC Aesthetics® FixNip™: Revolutionising Breast Reconstruction for women
Thursday, May 23, 2024
GC Aesthetics® (GCA®), the leading designer, manufacturer and distributor of breast implants and medical devices for the global aesthetics industry is providing a game-changing product with nothing else like it currently in the market.
FixNip™ NRI: The Nipple and Areola Reconstruction Implant is an unrivalled medical device that provides the answer to a well-known clinical need of thousands of women around the world. Until now, a variety of surgical techniques have been used to try to reconstruct the nipple-areola complex with none providing a long-term aesthetic solution.
GC Aesthetics® in an exclusive partnership agreement with FixNip LTD has launched FixNip NRI across the main European Territories with plans to further roll out the product to Latin America, Central Europe and Asia.
With this one-of-a-kind product, GC Aesthetics will spearhead expansion and growth into the Breast Reconstruction Segment, elevating and enhancing current standards.
FixNip™ NRI is produced from biocompatible smooth silicone with a floral-shaped nitinol frame which allows a minimal incision as its key to recover the original shape of the implant when it is folded and inserted.
It is estimated that around 30% of women diagnosed with breast cancer each year in the UK undergo a mastectomy, with 21% of these patients opting to have immediate breast reconstruction.
The FixNip NRI is implanted with a minimally invasive procedure carried out by surgeons which takes an average of 15 minutes to insert. The outcome has demonstrated high patient satisfaction with minimum patient downtime and an excellent safety profile.
“The NAC reconstruction procedure should be considered an integral part of breast reconstructive surgery,” says renowned French Plastic Surgeon Prof. Dr Michael Atlan.
“It gives women an important psychological contribution and leads to greater wellbeing, overall sense of self and high satisfaction after being reconstructed”.
Carlos Reis Pinto, CEO at GC Aesthetics®, said:
"We are committed to delivering safe options that establish a newer, higher, and more beneficial standard of care for women who seek total breast reconstruction. Such technology breakthroughs will complete our range of solutions dedicated to women's aesthetic healthcare. FixNip by GC Aesthetics is a healthcare game-changer”
Fara Naomi Macías, CMO of GCA, said:
“At GCA we believe a Total Breast Reconstruction is not only a choice, but a pathway for women to a full recovery after a mastectomy. We are extremely proud of adding this product to our portfolio and what it will represent for Reconstructive and Plastic Surgeons and the lives of thousands of women."
About GC Aesthetics:
GC Aesthetics® is a long-established global medical technology company that develops, manufactures, and markets a comprehensive range of proprietary aesthetic and reconstructive products.
Throughout its 40-year history, GCA® has been dedicated to advancing the science of medical aesthetics and delivering high-quality breast implants for breast augmentation and breast reconstructive surgery. We have sold more than 3 million implants across 70 countries, and our products are supported by published 10-year clinical data.